Afatinib versus methotrexate in older patients with second-line recurrent and/or metastatic head and neck squamous cell carcinoma: Subgroup analysis of the LUX-Head & Neck 1 trial

P. Clément, Thomas Gauler, Jean Pascal Machiels, Robert I. Haddad, J. Fayette, Makoto Tahara, Ezra E W Cohen, D. Cupissol, Juan José Grau, J. Guigay, Francesco Caponigro, Gilberto de Castro, Luciano de Souza Viana, Ulrich Keilholz, José Maria Del Campo, X. J. Cong, Eva Ehrnrooth, J. B. Vermorken

Research output: Contribution to journalArticlepeer-review

Fingerprint Dive into the research topics of 'Afatinib versus methotrexate in older patients with second-line recurrent and/or metastatic head and neck squamous cell carcinoma: Subgroup analysis of the LUX-Head & Neck 1 trial'. Together they form a unique fingerprint.

Medicine & Life Sciences